Home WebinarsLeveraging Process Analytical Technology for Developing Novel Conjugates

Leveraging Process Analytical Technology for Developing Novel Conjugates

WEBINAR

Join us for an insightful webinar designed to highlight the benefits you can gain from partnering with a top-tier Contract Development and Manufacturing Organization (CDMO). Discover how our advanced Antibody-Drug Conjugate (ADC) platform enables you to develop processes and manufacture a diverse range of novel conjugates to meet your specific drug development needs. We will highlight the advantages of focusing on Process Analytical Technology (PAT) and how its strategic integration into our development workflows enhances our technical capabilities. Learn how our commitment to PAT not only accelerates process development but also ensures the delivery of high-quality products from the start.

In this webinar, you will learn:

How to leverage a robust ADC platform to scale-up and manufacture multiple novel conjugates
Incorporation of Process Analytical Technology (PAT), can deepen process understanding and results in better data collection in fewer development runs
Utilization of PAT has led to faster, more efficient process development strengthening our First-Time-Right philosophy

Speakers

Melissa Ritchie

MilliporeSigma

Senior Scientist, Analytical Development

Melissa joined MilliporeSigma's process and analytical development team in 2018. She started her career as a fellow scientist at ORIS and FDA DPA and was a postdoc fellow at UNC Chapel Hill. With a strong background in protein biochemistry and bioconjungation, she has more than seven years of experience in the industry. Melissa holds a Ph.D. from the Wake Forest School of Medicine.

Sowmyan Sreenivasaraghavan

MilliporeSigma

Scientist, ADC Process Development

Sowmyan joined MilliporeSigma's process and analytical development team in 2019. Before his current role, he optimized mAb downstream processes within the MSAT operations and developed novel processes for dairy proteins and lipids. He has eight years of experience in industrial biotech and food science. Sowmyan holds an M.S. from the Ohio State University.